Funded Startups in Wayne
Across these 15 recent Wayne-area funding entries, the largest disclosed round is Cagent Vascular’s $15M (2025-02-20).
Across these 15 recent Wayne-area funding entries, the largest disclosed round is Cagent Vascular’s $15M (2025-02-20). That $15M figure is a clear outlier relative to the rest of the disclosed amounts in this slice, where most rounds cluster far lower (several are in the $2M–$4M range, while smaller disclose entries include $740K on 2025-07-17 for Jack Demmer Automotive Group and $100K on 2024-07-01 for Gnosko Bio). Notably, the list also contains four “undisclosed”/non-disclosed amounts (Palvella Therapeutics on 2024-12-13; Nurses 24/7 on 2023-07-12; Verdafresh on 2023-06-21; and the undisclosed “amount_usd” on the 2023-06-21 row).
The funding dates concentrate in a fairly tight window: most rows fall between 2024-01-11 and 2025-02-20, with the newest round dated 2025-07-17 (Jack Demmer Automotive Group) and the oldest dated 2022-02-01 (DuraStat). Sector-wise, biotechnology appears repeatedly (XyloCor Therapeutics on 2025-01-07 at $68M; Palvella Therapeutics on 2024-12-13 as undisclosed), alongside a strong presence of “Series Unknown” classifications (9 of 15 rows are labeled “Series Unknown” with some amounts undisclosed). Geography is not uniform either: Wayne appears across multiple state designations (Pennsylvania, Illinois, Michigan, and New Jersey), with the Pennsylvania listings dominating this set.
Most recent rounds
15 shownRelated listings
Frequently asked
What stands out in size, and is there a single outlier compared with the rest of the disclosed rounds?
Cagent Vascular’s $15M (2025-02-20) is the largest disclosed amount in this set and materially larger than most other disclosed rounds; for example, Jack Demmer Automotive Group is $740K (2025-07-17) and QualiFi is $4M (2024-12-04). Several others sit at lower disclosed tiers such as $2M (DuraStat, 2022-02-01) and $3M (Kivo, 2022-04-07).
Do the most recent funding rounds cluster in a specific period, or are they spread evenly over multiple years?
They cluster heavily in 2024–early 2025: 2024 has multiple entries (e.g., XyloCor Therapeutics on 2025-01-07 is followed by Palvella on 2024-12-13, QualiFi on 2024-12-04, and Golf Genius Software on 2024-02-13), and the largest disclosed amount is in early 2025 (Cagent Vascular on 2025-02-20). The date range of the 15 rows spans 2022-02-01 (DuraStat) through 2025-07-17 (Jack Demmer Automotive Group), but the middle years hold most records.
Which Wayne geography shows up most, and does the list mix multiple states under the same city name?
Yes, the city name “Wayne” is spread across multiple states in this slice, including Pennsylvania (e.g., XyloCor Therapeutics on 2025-01-07 at $68M and GrayHawk Health on 2023-05-09 at $13M), Michigan (Jack Demmer Automotive Group on 2025-07-17 at $740K), Illinois (INGENIOUS.BUILD on 2023-11-16 at $37M), and New Jersey (Nurses 24/7 on 2023-07-12 with undisclosed amount). Pennsylvania entries dominate the count of rows shown.
How does stage labeling break down, given the presence of “Series Unknown” and undisclosed amounts?
“Series Unknown” is the most common classification here: 9 of 15 rows are labeled “Series Unknown” (including Cagent Vascular on 2025-02-20 at $15M and Cornelis Networks on 2024-03-01 at $25M). There are also 4 rows with undisclosed amounts (Palvella Therapeutics on 2024-12-13, Nurses 24/7 on 2023-07-12, Verdafresh on 2023-06-21, and the undisclosed amount on the remaining “undisclosed” row), which reduces how precisely disclosed comparisons can be made.
Are biotechnology companies a noticeable cluster in this Wayne funding snapshot?
Biotechnology appears in at least two key rows within the most recent period: XyloCor Therapeutics (Series B, 2025-01-07, $68M) and Palvella Therapeutics (2024-12-13, amount undisclosed). This pairing sits alongside other “Series Unknown” funding in adjacent areas, but biotechnology is one of the clearer sector repeats in the top 15.
Within the most recent 90 days of the newest row, what kinds of deals show up most?
Relative to the newest date (2025-07-17 for Jack Demmer Automotive Group), the subsequent entries within that window include Cagent Vascular (2025-02-20 at $15M) and XyloCor Therapeutics (2025-01-07 at $68M). These same-window rounds also reinforce the sector/stage mix where “Series Unknown” is frequent (Cagent Vascular) while at least one biotech deal is explicitly staged (XyloCor Therapeutics, Series B).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.